Additional file 1: of Tumor regression mediated by oncogene withdrawal or erlotinib stimulates infiltration of inflammatory immune cells in EGFR mutant lung tumors
收藏DataCite Commons2020-08-26 更新2024-07-27 收录
下载链接:
https://springernature.figshare.com/articles/Additional_file_1_of_Tumor_regression_mediated_by_oncogene_withdrawal_or_erlotinib_stimulates_infiltration_of_inflammatory_immune_cells_in_EGFR_mutant_lung_tumors/8857745/1
下载链接
链接失效反馈官方服务:
资源简介:
Figure S1. MRI images, histology and representative flow cytometry plots of normal or tumor-bearing lungs before and after erlotinib. (A) Coronal images of CCSPrtTA; TetO-EGFRL858R mouse lungs before (left panel) and after (right panel) treatment with erlotinib. (B) Hematoxylin and eosin (H&E) stain of lungs from control (normal) and tumor bearing CCSP-rtTA; TetO-EGFRL858R mice in the absence (−) and presence (+) of erlotinib for 2 weeks. Bar: 50 μm. Absolute number of (C) CD4 and (D) CD8 T cells normalized to weight of lungs of control (normal) and tumor bearing CCSP-rtTA; TetO-EGFRL858R mice in the absence (−) and presence (+) of erlotinib for 2 weeks. Representative FACS plot showing percentage of (E) FoxP3+ and FoxP3- CD4+ T cells (F) PD1+ FoxP3+ T cells. (G) Immunofluorescence (IF) stain of lung epithelial cells (green), CD3 T cells (red) and FoxP3 Tregs (Cyan). Nuclei were counterstained with Dapi (blue) (H) Quantification of FoxP3+ CD3 T cells in lung tumor bearing CCSP-rtTA; TetO-EGFRL858R mice in the absence (−) and presence (+) of erlotinib for 2 weeks stained by IF. Data are shown as mean ± SD and * is P
补充图S1 厄洛替尼处理前后正常或荷瘤肺部的磁共振成像(Magnetic Resonance Imaging, MRI)图像、组织学切片及代表性流式细胞术图谱。(A) 经厄洛替尼处理前(左图)及处理后(右图)的CCSP-rtTA; TetO-EGFRL858R小鼠肺部冠状位MRI图像。(B) 未给予(−)及给予(+)厄洛替尼处理2周后,对照组(正常)及荷瘤CCSP-rtTA; TetO-EGFRL858R小鼠肺部的苏木精-伊红(Hematoxylin and eosin, H&E)染色结果。标尺:50 μm。(C) 及(D) 分别为未给予(−)及给予(+)厄洛替尼处理2周后,对照组(正常)及荷瘤CCSP-rtTA; TetO-EGFRL858R小鼠肺部CD4⁺T细胞与CD8⁺T细胞的绝对计数(以肺部重量标准化后的数值)。(E) 代表性荧光激活细胞分选(Fluorescence Activated Cell Sorting, FACS)散点图,展示叉头框蛋白P3(Forkhead box P3, FoxP3)⁺与FoxP3⁻ CD4⁺T细胞的占比;(F) 程序性死亡蛋白1(Programmed Cell Death Protein 1, PD1)⁺ FoxP3⁺ T细胞的占比。(G) 肺部上皮细胞(绿色)、CD3⁺T细胞(红色)及FoxP3⁺调节性T细胞(青色)的免疫荧光(Immunofluorescence, IF)染色结果。细胞核经4',6-二脒基-2-苯基吲哚(4',6-Diamidino-2-Phenylindole, DAPI)复染(蓝色)。(H) 免疫荧光染色后,对未给予(−)及给予(+)厄洛替尼处理2周的荷瘤CCSP-rtTA; TetO-EGFRL858R小鼠肺部FoxP3⁺CD3⁺T细胞的定量分析结果。数据以均值±标准差(Standard Deviation, SD)展示,*代表P
提供机构:
figshare
创建时间:
2019-07-11



